115 related articles for article (PubMed ID: 10365723)
1. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
Wolfe JL; Thoma LA; Du C; Goldspiel BR; Gallelli JF; Grimes GJ; Potti GK
Am J Health Syst Pharm; 1999 May; 56(10):985-9. PubMed ID: 10365723
[No Abstract] [Full Text] [Related]
2. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Yuan P; Grimes GJ; Shankman SE; Daniels CE; Goldspiel BR; Potti GK
Am J Health Syst Pharm; 2001 Apr; 58(7):594-8. PubMed ID: 11296609
[No Abstract] [Full Text] [Related]
3. Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastomeric pump supporting transition of the EPOCH regimen to outpatient care.
Svirskis D; Behera S; Naidoo N; Beachman J; Raina T; Zhou Y; Berkahn L; Costello I; Gu Y
J Oncol Pharm Pract; 2019 Jun; 25(4):831-840. PubMed ID: 29540104
[TBL] [Abstract][Full Text] [Related]
4. Stability of intravenous admixtures of doxorubicin and vincristine.
Beijnen JH; Neef C; Meuwissen OJ; Rutten JJ; Rosing H; Underberg WJ
Am J Hosp Pharm; 1986 Dec; 43(12):3022-7. PubMed ID: 3812509
[TBL] [Abstract][Full Text] [Related]
5. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C.
Trissel LA; Xu Q; Martinez JF; Fox JL
Am J Hosp Pharm; 1994 Sep; 51(17):2138-42. PubMed ID: 7527184
[TBL] [Abstract][Full Text] [Related]
6. Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
Bougouin C; Thelcide C; Crespin-Maillard F; Maillard C; Kinowski JM; Favier M
Am J Health Syst Pharm; 2005 Oct; 62(19):2001-5. PubMed ID: 16174836
[TBL] [Abstract][Full Text] [Related]
7. Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers.
Barthes DM; Rochard EB; Pouliquen IJ; Rabouan SM; Courtois PY
Am J Hosp Pharm; 1994 Nov; 51(21):2706-9. PubMed ID: 7856587
[No Abstract] [Full Text] [Related]
8. Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection.
Ku YM; Min DI; Kumar V; Noormohamed SE
Am J Health Syst Pharm; 1995 Sep; 52(18):2024-5. PubMed ID: 8528874
[No Abstract] [Full Text] [Related]
9. Stability of doxorubicin hydrochloride and vincristine sulfate in two portable infusion-pump reservoirs.
Nyhammar EK; Johansson SG; Seiving BE
Am J Health Syst Pharm; 1996 May; 53(10):1171-3. PubMed ID: 8734681
[No Abstract] [Full Text] [Related]
10. Stability and compatibility of antitumor agents in glass and plastic containers.
Benvenuto JA; Anderson RW; Kerkof K; Smith RG; Loo TL
Am J Hosp Pharm; 1981 Dec; 38(12):1914-8. PubMed ID: 7325172
[TBL] [Abstract][Full Text] [Related]
11. Stability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bags.
Stewart JT; Warren FW; King DT; Venkateshwaran TG; Ponder GW; Fox JL
Am J Health Syst Pharm; 1997 Apr; 54(8):915-20. PubMed ID: 9114924
[No Abstract] [Full Text] [Related]
12. Stability of cisplatin and etoposide in intravenous admixtures.
Stewart CF; Hampton EM
Am J Hosp Pharm; 1989 Jul; 46(7):1400-4. PubMed ID: 2757048
[TBL] [Abstract][Full Text] [Related]
13. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Trissel LA; Gilbert DL; Martinez JF
Am J Health Syst Pharm; 1997 Dec; 54(23):2708-13. PubMed ID: 9408515
[TBL] [Abstract][Full Text] [Related]
14. Compatibility of bupivacaine hydrochloride and morphine sulfate.
Johnson CE; Christen C; Perez MM; Ma M
Am J Health Syst Pharm; 1997 Jan; 54(1):61-4. PubMed ID: 9117792
[No Abstract] [Full Text] [Related]
15. Stability of ranitidine hydrochloride and human insulin in 0.9% sodium chloride injection.
Nolan PE; Hoyer GL; LeDoux JH; Fox JL
Am J Health Syst Pharm; 1997 Jun; 54(11):1304-6. PubMed ID: 9179353
[No Abstract] [Full Text] [Related]
16. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
Woloschuk DM; Wermeling JR; Pruemer JM
Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
[TBL] [Abstract][Full Text] [Related]
17. Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32 degrees C.
Xu Q; Trissel LA; Martinez JF
Am J Hosp Pharm; 1994 Dec; 51(24):3058-60. PubMed ID: 7856626
[No Abstract] [Full Text] [Related]
18. Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions.
Trissel LA; Xu QA; Gilbert DL
Ann Pharmacother; 1998 Oct; 32(10):1013-6. PubMed ID: 9793591
[TBL] [Abstract][Full Text] [Related]
19. Compatibility of fentanyl citrate, ketamine hydrochloride, and droperidol in 0.9% sodium chloride injection stored in polyvinyl chloride bags.
Lee DK; Wang DP; Harsono R; Wong CY
Am J Health Syst Pharm; 2005 Jun; 62(11):1190-2. PubMed ID: 15914879
[No Abstract] [Full Text] [Related]
20. Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection.
Kintzel PE; Zhao T; Wen B; Sun D
Am J Health Syst Pharm; 2014 Dec; 71(23):2061-5. PubMed ID: 25404598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
